Romi Ghose

1.4k total citations
45 papers, 1.1k citations indexed

About

Romi Ghose is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Romi Ghose has authored 45 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 26 papers in Molecular Biology and 15 papers in Pharmacology. Recurrent topics in Romi Ghose's work include Drug Transport and Resistance Mechanisms (19 papers), Pharmacogenetics and Drug Metabolism (12 papers) and Cancer therapeutics and mechanisms (12 papers). Romi Ghose is often cited by papers focused on Drug Transport and Resistance Mechanisms (19 papers), Pharmacogenetics and Drug Metabolism (12 papers) and Cancer therapeutics and mechanisms (12 papers). Romi Ghose collaborates with scholars based in United States, China and Netherlands. Romi Ghose's co-authors include Adarsh Gandhi, Saul J. Karpen, Bhagavatula Moorthy, Sundararajah Thevananther, Tracy L. Zimmerman, Pranav Shah, Tao Guo, Tao Guo, Andrew P. Rice and Christine Herrmann and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Molecular and Cellular Biology.

In The Last Decade

Romi Ghose

44 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Romi Ghose United States 19 444 397 297 138 137 45 1.1k
Lydiane Pichard‐Garcia France 18 348 0.8× 519 1.3× 845 2.8× 189 1.4× 365 2.7× 27 1.8k
Ying Mu United States 14 361 0.8× 425 1.1× 406 1.4× 66 0.5× 222 1.6× 23 1.2k
Chenglai Xia China 24 691 1.6× 193 0.5× 79 0.3× 183 1.3× 131 1.0× 61 1.4k
John C. Marecki United States 18 460 1.0× 100 0.3× 109 0.4× 106 0.8× 190 1.4× 30 1.5k
Annie Borgne‐Sanchez France 14 425 1.0× 125 0.3× 267 0.9× 62 0.4× 260 1.9× 19 1.0k
Sumathy Mathialagan United States 21 341 0.8× 643 1.6× 300 1.0× 274 2.0× 102 0.7× 41 1.3k
Claire Guyomard France 14 404 0.9× 251 0.6× 372 1.3× 94 0.7× 557 4.1× 20 1.7k
Barbara Jaruga United States 17 356 0.8× 433 1.1× 216 0.7× 593 4.3× 576 4.2× 21 1.6k
Michael J. Hafey United States 10 579 1.3× 525 1.3× 112 0.4× 56 0.4× 86 0.6× 16 985
Jean-Claude Ourlin France 13 300 0.7× 359 0.9× 528 1.8× 119 0.9× 95 0.7× 19 1.3k

Countries citing papers authored by Romi Ghose

Since Specialization
Citations

This map shows the geographic impact of Romi Ghose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Romi Ghose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Romi Ghose more than expected).

Fields of papers citing papers by Romi Ghose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Romi Ghose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Romi Ghose. The network helps show where Romi Ghose may publish in the future.

Co-authorship network of co-authors of Romi Ghose

This figure shows the co-authorship network connecting the top 25 collaborators of Romi Ghose. A scholar is included among the top collaborators of Romi Ghose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Romi Ghose. Romi Ghose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tao, Gabriel, et al.. (2022). Irinotecan decreases intestinal UDP-glucuronosyltransferase (UGT) 1A1 via TLR4/MyD88 pathway prior to the onset of diarrhea. Food and Chemical Toxicology. 166. 113246–113246. 10 indexed citations
2.
Tao, Gabriel, et al.. (2022). Development of a physiologically based pharmacokinetic model to predict irinotecan disposition during inflammation. Chemico-Biological Interactions. 360. 109946–109946. 3 indexed citations
3.
Tao, Gabriel, et al.. (2020). Role of oxidative stress in the efficacy and toxicity of herbal supplements. Current Opinion in Toxicology. 20-21. 36–40. 9 indexed citations
4.
Wu, Lei, et al.. (2019). Effects of inflammation on irinotecan pharmacokinetics and development of a best-fit PK model. Chemico-Biological Interactions. 316. 108933–108933. 8 indexed citations
5.
Maity, Suman Kumar, et al.. (2019). Transcriptomic profiling identifies novel mechanisms of transcriptional regulation of the cytochrome P450 (Cyp)3a11 gene. Scientific Reports. 9(1). 6663–6663. 15 indexed citations
6.
Basu, Sumit, et al.. (2017). Role of Toll-like receptor 4 in drug-drug interaction between paclitaxel and irinotecan in vitro. Toxicology in Vitro. 41. 75–82. 7 indexed citations
7.
Ghose, Romi, et al.. (2016). In Vitro Approaches to Study Regulation of Hepatic Cytochrome P450 (CYP) 3A Expression by Paclitaxel and Rifampicin. Methods in molecular biology. 1395. 55–68. 9 indexed citations
8.
Shah, Pranav, et al.. (2015). Impact of obesity on accumulation of the toxic irinotecan metabolite, SN-38, in mice. Life Sciences. 139. 132–138. 9 indexed citations
9.
Shah, Pranav, Ozozoma Omoluabi, Bhagavatula Moorthy, & Romi Ghose. (2015). Role of Adaptor Protein Toll-Like Interleukin Domain Containing Adaptor Inducing Interferon β in Toll-Like Receptor 3- and 4-Mediated Regulation of Hepatic Drug Metabolizing Enzyme and Transporter Genes. Drug Metabolism and Disposition. 44(1). 61–67. 10 indexed citations
10.
Gandhi, Adarsh, Bhagavatula Moorthy, & Romi Ghose. (2012). Drug Disposition in Pathophysiological Conditions. Current Drug Metabolism. 13(9). 1327–1344. 61 indexed citations
11.
Fahy, Bridget N., Tao Guo, & Romi Ghose. (2012). Impact of hepatic malignancy on CYP3A4 gene expression. Journal of Surgical Research. 178(2). 768–772. 5 indexed citations
12.
Guo, Tao, et al.. (2012). CYP3A‐dependent drug metabolism is reduced in bacterial inflammation in mice. British Journal of Pharmacology. 166(7). 2176–2187. 26 indexed citations
13.
Ghose, Romi, Tao Guo, Jesús G. Vallejo, & Adarsh Gandhi. (2011). Differential Role of Toll-Interleukin 1 Receptor Domain-Containing Adaptor Protein in Toll-Like Receptor 2-Mediated Regulation of Gene Expression of Hepatic Cytokines and Drug-Metabolizing Enzymes. Drug Metabolism and Disposition. 39(5). 874–881. 29 indexed citations
14.
Tam, Vincent H., Kimberly R. Ledesma, Amy N. Schilling, et al.. (2009). In vivo dynamics of carbapenem-resistant Pseudomonas aeruginosa selection after suboptimal dosing. Diagnostic Microbiology and Infectious Disease. 64(4). 427–433. 16 indexed citations
16.
Ghose, Romi, Jaap Mulder, Richard J. von Furstenberg, et al.. (2006). Rosiglitazone attenuates suppression of RXRα-dependent gene expression in inflamed liver. Journal of Hepatology. 46(1). 115–123. 30 indexed citations
17.
Zimmerman, Tracy L., Sundararajah Thevananther, Romi Ghose, Alan R. Burns, & Saul J. Karpen. (2006). Nuclear Export of Retinoid X Receptor α in Response to Interleukin-1β-mediated Cell Signaling. Journal of Biological Chemistry. 281(22). 15434–15440. 83 indexed citations
18.
Ghose, Romi, et al.. (2004). Restricted Specificity of Xenopus TFIIIA for Transcription of Somatic 5S rRNA Genes. Molecular and Cellular Biology. 24(6). 2467–2477. 6 indexed citations
19.
Westmark, Cara J., Romi Ghose, & Paul W. Huber. (2002). Phosphorylation of Xenopus transcription factor IIIA by an oocyte protein kinase CK2. Biochemical Journal. 362(2). 375–375. 9 indexed citations
20.
Ghose, Romi, et al.. (2000). Disposition kinetics of ofloxacin in Black Bengal goats following single oral administration.. Indian Journal of Animal Health. 39(2). 56–60. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026